Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001387131-20-004411
Filing Date
2020-05-04
Accepted
2020-05-04 17:03:29
Documents
3
Effectiveness Date
2020-05-04

Document Format Files

Seq Description Document Type Size
1 ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS txmd-defa14a_061820.htm DEFA14A 46861
2 GRAPHIC txmd-def14a001.jpg GRAPHIC 2529
3 GRAPHIC txmd-def14a002.jpg GRAPHIC 2057
  Complete submission text file 0001387131-20-004411.txt   54716
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-00100 | Film No.: 20845729
SIC: 2834 Pharmaceutical Preparations